Inst Diagnosti (INDISA) - Total Liabilities

Latest as of June 2025: CL$191.22 Billion CLP ≈ $213.85 Million USD

Based on the latest financial reports, Inst Diagnosti (INDISA) has total liabilities worth CL$191.22 Billion CLP (≈ $213.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Inst Diagnosti operating cash flow efficiency to assess how effectively this company generates cash.

Inst Diagnosti - Total Liabilities Trend (2014–2024)

This chart illustrates how Inst Diagnosti's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Inst Diagnosti's assets to evaluate the company's liquid asset resilience ratio.

Inst Diagnosti Competitors by Total Liabilities

The table below lists competitors of Inst Diagnosti ranked by their total liabilities.

Company Country Total Liabilities
Yunnan Metropolitan Real Estate Development Co Ltd
SHG:600239
China CN¥8.32 Billion
Guangdong New Grand Long Packing Co Ltd
SHE:002836
China CN¥150.36 Million
Leenos Corp
KQ:039980
Korea ₩11.99 Billion
Shanghai Tianyong Engineering Co Ltd
SHG:603895
China CN¥1.02 Billion
EVS Broadcast Equipment SA
BR:EVS
Belgium €66.59 Million
China Datang Corporation Renewable Power Co. Limited
F:DT7
Germany €77.62 Billion
Dalian Zhiyun Automation Co Ltd
SHE:300097
China CN¥420.80 Million
Beijing Transtrue Technology Inc
SHE:002771
China CN¥289.55 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Inst Diagnosti's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Inst Diagnosti.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inst Diagnosti's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inst Diagnosti (2014–2024)

The table below shows the annual total liabilities of Inst Diagnosti from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 CL$163.28 Billion
≈ $182.60 Million
-5.38%
2023-12-31 CL$172.56 Billion
≈ $192.98 Million
+0.75%
2022-12-31 CL$171.26 Billion
≈ $191.53 Million
+26.20%
2021-12-31 CL$135.71 Billion
≈ $151.77 Million
+38.62%
2020-12-31 CL$97.90 Billion
≈ $109.49 Million
+13.08%
2019-12-31 CL$86.58 Billion
≈ $96.82 Million
-0.96%
2018-12-31 CL$87.42 Billion
≈ $97.76 Million
-3.79%
2017-12-31 CL$90.86 Billion
≈ $101.61 Million
-0.33%
2016-12-31 CL$91.16 Billion
≈ $101.95 Million
+15.85%
2015-12-31 CL$78.69 Billion
≈ $88.00 Million
+27.89%
2014-12-31 CL$61.53 Billion
≈ $68.81 Million
--

About Inst Diagnosti

SN:INDISA Chile Medical Care Facilities
Market Cap
$453.40 Million
CL$405.42 Billion CLP
Market Cap Rank
#13057 Global
#55 in Chile
Share Price
CL$2648.30
Change (1 day)
+0.00%
52-Week Range
CL$1982.90 - CL$2889.90
All Time High
CL$2889.90
About

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more